Next Article in Journal / Special Issue
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
Previous Article in Journal
Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
Previous Article in Special Issue
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Review

The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide

1
Instituto de Productos Lácteos de Asturias (IPLA-CSIC), (DairySafe Group), Paseo Río Linares s/n -Villaviciosa, 33300 Asturias, Spain
2
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain
3
Laboratory of Applied Biotechnology, Department of Applied Biosciences, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium
*
Author to whom correspondence should be addressed.
Received: 29 July 2019 / Revised: 19 August 2019 / Accepted: 21 August 2019 / Published: 23 August 2019
(This article belongs to the Special Issue Feature Paper in Antibiotics for 2019)
The alarming spread of multiresistant infections has kick-started the quest for alternative antimicrobials. In a way, given the steady increase in untreatable infectious diseases, success in this endeavor has become a matter of life and death. Perhaps we should stop searching for an antibacterial panacea and explore a multifaceted strategy in which a wide range of compounds are available on demand depending on the specific situation. In the context of this novel tailor-made approach to combating bacterial pathogens, the once forgotten phage therapy is undergoing a revival. Indeed, the compassionate use of bacteriophages against seemingly incurable infections has been attracting a lot of media attention lately. However, in order to take full advantage of this strategy, bacteria’s natural predators must be taken from their environment and then carefully selected to suit our needs. In this review, we have explored the vast literature regarding phage isolation and characterization for therapeutic purposes, paying special attention to the most recent studies, in search of findings that hint at the most efficient strategies to identify suitable candidates. From this information, we will list and discuss the traits that, at the moment, are considered particularly valuable in phages destined for antimicrobial therapy applications. Due to the growing importance given to biofilms in the context of bacterial infections, we will dedicate a specific section to those characteristics that indicate the suitability of a bacteriophage as an antibiofilm agent. Overall, the objective is not just to have a large collection of phages, but to have the best possible candidates to guarantee elimination of the target pathogens. View Full-Text
Keywords: bacteriophages; biofilms; novel antimicrobials bacteriophages; biofilms; novel antimicrobials
Show Figures

Figure 1

MDPI and ACS Style

Fernández, L.; Gutiérrez, D.; García, P.; Rodríguez, A. The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide. Antibiotics 2019, 8, 126. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics8030126

AMA Style

Fernández L, Gutiérrez D, García P, Rodríguez A. The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide. Antibiotics. 2019; 8(3):126. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics8030126

Chicago/Turabian Style

Fernández, Lucía; Gutiérrez, Diana; García, Pilar; Rodríguez, Ana. 2019. "The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide" Antibiotics 8, no. 3: 126. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics8030126

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop